⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14839962 | 0.80 | — | — | |
| Water SCHEMBL25298648 | 0.78 | — | — | |
| SCHEMBL3683085 | 0.76 | DPP4 (0.33) | — | |
| SCHEMBL6015915 | 0.74 | DPP4 (0.38) | — | |
| SCHEMBL6436338 | 0.74 | — | — | |
| Water SCHEMBL1335270 | 0.72 | DPP4 (0.31) | — | |
| SCHEMBL30073234 | 0.71 | DPP4 (0.37) | — | |
| SCHEMBL28465066 | 0.70 | — | — | |
| SCHEMBL30762305 | 0.70 | DPP4 (0.36) | — | |
| SCHEMBL11509040 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190142792-A1 | ANTIVIRAL EPICATECHINS, EPICATECHIN OLIGOMERS, OR THIOLATED EPICATECHINS FROM THEOBROMA CACAO FOR TREATMENT OF GENITAL WARTS | CACAO BIO-TECHNOLOGIES, LLC (US) | 2019-05-16 | — | — | US | claimed |
| US-20170035726-A1 | ANTIVIRAL EPICATECHINS, EPICATECHIN OLIGOMERS, OR THIOLATED EPICATECHINS FROM THEOBROMA CACAO FOR TREATMENT OF GENITAL WARTS | CACAO BIO-TECHNOLOGIES, LLC (US) | 2017-02-09 | — | — | US | claimed |
| US-20150011488-A1 | ANTIVIRAL EPICATECHINS, EPICATECHIN OLIGOMERS, OR THIOLATED EPICATECHINS FROM THEOBROMA CACAO FOR TREATMENT OF GENITAL WARTS | CACAO BIO-TECHNOLOGIES, LLC (US) | 2015-01-08 | — | — | US | claimed |
| US-8084015-B2 | Immunostimulatory complex of a cationic peptide immunogen and anionic CpG single-stranded DNA oligonucleotide | UNITED BIOMEDICAL, INC. (US) | 2011-12-27 | — | — | US | claimed |
| US-7122192-B2 | Porcine circoviruses, vaccines and diagnostic reagents | MERIAL SAS (FR) | 2006-10-17 | — | — | US | claimed |
| EP-4380617-A1 | MULTIVALENT PAN-INFLUENZA VACCINE | Najit Technologies, Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| EP-3454895-B1 | INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION | NAJIT TECH INC (US) | 2024-03-27 | — | — | EP | disclosed |
| US-11844832-B2 | Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production | NAJIT TECHNOLOGIES, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| US-20230346910-A1 | INACTIVATING PATHOGENS AND PRODUCING HIGHLY IMMUNOGENIC INACTIVATED VACCINES USING A DUAL OXIDATION PROCESS | Najít Technologies, Inc. | 2023-11-02 | — | — | US | disclosed |
| US-11633470-B2 | Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process | NAJIT TECHNOLOGIES, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| WO-2023015145-A1 | MULTIVALENT PAN-INFLUENZA VACCINE | NAJIT TECHNOLOGIES, INC. (US) | 2023-02-09 | — | — | WO | disclosed |
| US-20220241395-A1 | INACTIVATING PATHOGENS AND PRODUCING HIGHLY IMMUNOGENIC INACTIVATED VACCINES USING A DUAL OXIDATION PROCESS | Najít Technologies, Inc. | 2022-08-04 | — | — | US | disclosed |
| US-5403586-A | Vaccines of TraT protein complexes; antifertility agents; contraceptives; veterinary medicine; side effect reduction; genetic engineering | BIOTECHNOLOGY AUSTRALIA PTL LTD. (AU) | 1995-04-04 | — | — | US | disclosed |
| EP-0661967-A4 | COMBINED VIRUSTATIC ANTIMEDIATOR (COVAM) TREATMENT OF COMMON COLDS. | UNIV VIRGINIA (US) | 1994-09-29 | — | — | EP | disclosed |
| US-5240694-A | Combined antiviral and antimediator treatment of common colds | UNIVERSITY OF VIRGINIA (US) | 1993-08-31 | — | — | US | disclosed |
| WO-1993009764-A1 | COMBINED VIRUSTATIC ANTIMEDIATOR (COVAM) TREATMENT OF COMMON COLDS | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1993-05-27 | — | — | WO | disclosed |
| WO-1992013890-A1 | NEMATODE VACCINE | BIOTECH AUSTRALIA PTY LIMITED (AU) | 1992-08-20 | — | — | WO | disclosed |
| EP-0458937-A4 | VARIANTS OF PAI-2 | — | 1992-04-01 | — | — | EP | disclosed |
| EP-0458937-A1 | VARIANTS OF PAI-2. | BIOTECH AUSTRALIA PTY LTD (AU) | 1991-12-04 | — | — | EP | disclosed |
| WO-1991009124-A1 | VARIANTS OF PAI-2 | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1991-06-27 | — | — | WO | disclosed |